Moreover, the potential of the immunoplatforms for multiplexing has been demonstrated for the determination of endogenous total and glycosylated Hp content in the secretomes from CRC cells with different metastatic potentials in approx. 75 min. This evidence concerns the gene HP and colorectal carcinoma.